U.S. Consumer Finance Stock News

BlackRock (BLK) has drawn fresh attention after launching the iShares Staked Ethereum Trust ETF, ETHB. This gives stock investors a new reference point for how the firm is approaching crypto related products. See our latest analysis for BlackRock. Despite the crypto product headlines, BlackRock’s share price has had a softer patch, with a 30 day share price return of 9.63% and a year to date share price return of 10.76%. The 1 year total shareholder return of 3.24% and 3 year total...

Insmed (NasdaqGS:INSM) has launched Brinsupri, also known as brensocatib, for non cystic fibrosis bronchiectasis. Brinsupri is the first approved therapy for this condition and has already generated significant initial sales. The successful launch marks a material commercial milestone for Insmed and adds a new revenue stream alongside its existing portfolio. Insmed focuses on treatments for serious and rare respiratory diseases, so the approval and rollout of Brinsupri fit directly into its...

Earlier in March 2026, Bristol Myers Squibb reported positive interim Phase 3 SUCCESSOR-2 results for oral mezigdomide in relapsed or refractory multiple myeloma, and separately secured U.S. FDA approval for Sotyktu to treat adults with active psoriatic arthritis. Together, these milestones highlight Bristol Myers Squibb’s efforts to extend its leadership in targeted protein degradation and expand Sotyktu’s reach into immune-mediated diseases. We’ll now examine how the mezigdomide...

AngloGold Ashanti reported record 2025 output of 500,000 ounces at its Sukari mine, now classified as a Tier 1 asset and contributing 16% of group production after the Centamin acquisition. This surge in Sukari’s importance, combined with ongoing efficiency work under the Full Asset Potential program, is drawing increased attention from analysts ahead of the upcoming earnings release. We’ll now examine how Sukari’s record production and growing role in AngloGold Ashanti’s portfolio affects...

Recent performance context for Exxon Mobil (XOM) Exxon Mobil (XOM) has drawn investor attention after recent share price moves, with a past 3 months total return of 35.2% and a 1 year total return of 41.2%. Over the past month the stock returned 6.2%, while the past week showed a 4.0% gain following a modest 0.8% decline in the last trading day. See our latest analysis for Exxon Mobil. Viewed together, Exxon Mobil’s recent share price return of 3.96% over 7 days and 6.16% over 30 days sits on...

Carter's (CRI) has attracted investor attention after recent trading saw the share price at $34.51, with mixed return patterns over the past year prompting closer scrutiny of the childrenswear company’s fundamentals and valuation. See our latest analysis for Carter's. The recent pullback, including a 13.83% 1 month share price return and an 11.67% 1 year total shareholder return, suggests momentum has cooled after a modest 3.95% year to date share price gain. If Carter's price action has you...

The recent conflict in Iran has disrupted fertilizer shipments through the Strait of Hormuz, tightening global nitrogen supply just as CVR Partners entered 2026 with an unusually strong order book and earlier-than-normal ammonia movements across key farming regions. This combination of supply constraints and accelerated demand has created one of the strongest pricing backdrops for CVR Partners’ nitrogen fertilizers in years, underscoring how geopolitics can abruptly reshape fundamentals in a...

Capital Clean Energy Carriers (CCEC) recently sold 12 container vessels, raised about US$472.2 million in net proceeds, and redirected that capital into gas transportation assets, including newbuilding LNG carriers on long-term charters. See our latest analysis for Capital Clean Energy Carriers. Despite the recent asset sales and LNG charter wins, the share price is around US$20.21 with a 30 day share price return of about an 11% decline. The 1 year total shareholder return of 5.67% and 3...

Walker & Dunlop stock moves after extended share price slide Walker & Dunlop (WD) is drawing fresh attention after a sharp share price slide, with the stock showing negative returns over the past month, past 3 months, year to date, and past year. See our latest analysis for Walker & Dunlop. The 30 day share price return of 27.48% and 90 day share price return of 27.21% underline a clear loss of momentum. At the same time, the 1 year total shareholder return of 45.38% and 5 year total...

On March 18, 2026, Ingredion Incorporated announced its board declared a quarterly dividend of US$0.82 per share payable April 21, 2026, and confirmed a global AI-driven R&D collaboration with Shiru to develop novel natural prebiotic and functional protein ingredients for food, beverage, supplements, and specialized nutrition customers. This tie-up gives Shiru access to Ingredion’s scale and 18,000-plus customer relationships across 120 countries, potentially speeding real-world adoption of...

If you are wondering whether Reddit's current share price really reflects what you are getting as an investor, this article looks closely at what the numbers indicate about value. Reddit recently closed at US$142.79, with returns of 4.1% over the last 7 days, 2.2% over 30 days, a 41.0% decline year to date, and 29.9% over the last year. Recent headlines have focused on Reddit's position as a major online community platform and its ongoing role in broader market conversations. These stories...

comScore FY 2025 earnings snapshot comScore (SCOR) just closed out FY 2025 with Q4 revenue of US$93.5 million and basic EPS of US$12.77, alongside full year trailing twelve month figures showing revenue of US$357.5 million and a net loss of US$101.8 million. Over recent quarters the company has seen revenue move in a narrow band between US$85.7 million and US$94.9 million per quarter. At the same time, basic EPS has swung from a loss of US$12.79 to a profit of US$12.77. This leaves investors...

Spyre Therapeutics (SYRE) is back in focus after completing recruitment for the rheumatoid arthritis arm of its SKYWAY Phase 2 trial, which has pulled forward the expected topline readout to the third quarter of 2026. See our latest analysis for Spyre Therapeutics. At a share price of $43.06, Spyre’s momentum has been strong, with a 30 day share price return of 17.55% and a 90 day gain of 28.65%. The 1 year total shareholder return of 134.02% and 3 year total shareholder return above 4x...

Infleqtion (NYSE:INFQ) has delivered the UK’s first operational 100-qubit quantum computer to the National Quantum Computing Centre. The system is based on Infleqtion’s Sqale platform and is the only operational 100-physical-qubit quantum computing system currently installed in a UK national facility. This deployment gives UK researchers and industry direct access to larger scale neutral atom hardware for benchmarking and application testing. For investors watching quantum hardware,...

In March 2026, Enphase Energy announced collaborations with Ensol in France, Vistra in Texas, and Capital Good Fund in the US to expand IQ Battery and microinverter deployments via subscription models, virtual power plants, and enhanced financing access. These partnerships highlight Enphase’s push to embed its hardware into grid services and community-based programs, potentially deepening recurring, service-oriented revenue streams. Next, we’ll examine how Enphase’s expanded virtual power...

Peabody Energy (BTU) is back in focus after a sharp move in global coal prices linked to Middle East supply disruptions, with rising Asian demand aligning with its seaborne growth plans and the ramp up of the Centurion mine. See our latest analysis for Peabody Energy. The recent 2.4% 1 day share price return, on top of a 20.5% 90 day share price return and a very large 5 year total shareholder return, suggests momentum is building as investors reassess Peabody Energy’s risk and growth profile...

Earlier this month, Littelfuse, Inc. amended and restated its credit agreement, increasing its senior unsecured revolving credit facility from US$700 million to US$800 million and extending the maturity to March 12, 2031, while also appointing Trane Technologies executive Holly B. Paeper to its board and Technology Committee. The larger, longer-dated revolving credit line and addition of a board member with deep electrification and thermal management experience could shape how Littelfuse...

If you are wondering whether Hercules Capital's share price reflects its true worth, the recent mix of returns gives you plenty to think about before making any long term decisions. The stock closed at US$14.46 after a 0.7% gain over the past week, set against a 7.2% decline over 30 days, a 23.3% decline year to date, and a 15.1% decline over 1 year. Over longer periods, the 3 year and 5 year returns sit at 65.0% and 60.9% respectively. Recent coverage has focused on Hercules Capital's share...

Palomar Holdings (NasdaqGS:PLMR) reported strong fourth quarter results, with revenue figures that were materially ahead of earlier analyst expectations. The quarter highlighted performance in the company’s catastrophe insurance focus, an area closely watched by investors given recent weather and loss events. This update reflects current operating momentum for Palomar’s specialty insurance franchise and has not been widely discussed in recent coverage. Palomar focuses on specialty and...

ICL Group has opened a new specialty Water Soluble Fertilizer facility in Maharashtra, India, replicating its Israeli production model to support local manufacturing, diversify supply routes and reduce reliance on disrupted import channels after the closure of the Strait of Hormuz. This investment deepens ICL’s three-decade presence in India, where it already generates about US$250 million in annual revenues, and aligns tightly with the government’s “Make in India” push for more resilient...

Earlier this month, Teradyne introduced three AI-focused platforms: Photon 100 for silicon photonics and co-packaged optics, Omnyx for AI/data center PCBA testing, and Universal Robots’ UR AI Trainer for factory-scale physical AI model training. Together, these launches show Teradyne pushing deeper into the AI and data center ecosystem, spanning chip-level photonics, board-level testing, and AI-enabled robotics. We’ll now explore how Teradyne’s push into silicon photonics and co-packaged...

New Hialeah lease underlines active portfolio management Terreno Realty (TRNO) recently signed a lease for 88,000 square feet at Countyline Corporate Park Building 25 in Hialeah, Florida with an export and reverse logistics provider, after arranging an early termination with the outgoing tenant. The agreement runs from July 1, 2026 through December 2031, giving investors fresh detail on the REIT’s leasing activity in one of its six coastal U.S. industrial markets, as well as the potential...

Amneal Pharmaceuticals (AMRX) is back in focus after reporting 2025 results, with revenue of US$3.02b, operating income of US$421m, and lower net leverage of 3.5x, alongside 2026 guidance pointing to adjusted EBITDA and EPS growth. See our latest analysis for Amneal Pharmaceuticals. The recent pullback, including a 16.4% 1 month share price return decline to US$12.39, sits against a much stronger backdrop. The 1 year total shareholder return is 41.9%, and the 3 year total shareholder return...

If you are wondering whether Mercury General at around US$87.85 is still offering value or if most of the opportunity has already played out, this overview helps you frame that question clearly. The stock has pulled back with a 0.8% decline over 7 days and a 6.0% decline over 30 days, following very strong returns of 56.5% over 1 year, 216.2% over 3 years and 71.8% over 5 years. Recent attention around the stock has focused on its longer term share price performance and how that compares...